In today's edition of The Capitals, read about France and its allies urging to keep key chemical production in Europe, the collapse of Czech PM’s security talks after the opposition walked away, and so much more.
In total, EU countermeasures could apply to US exports worth up to €26 billion—mirroring the economic scale of the US tariffs.
The Commission has not yet published the full list of medicines it wants to include, alarming the pharma industry and patients alike.
The eight countries asked the European Commission to propose a “Critical Chemicals Act.”
The succession of political crises has led to heightened public disenchantment with traditional political institutions.
"The ball is in Russia's court," US Secretary of State Marco Rubio said after the talks.
The inclusion of waste incineration facilities in the ETS creates an incentive to landfill that has to be tackled, according to a Commission official.
Trump said in a post on Truth Social he would add an additional 25% tariff on Canadian steel and aluminium, to go into effect on Wednesday morning.
Europe's gravest economic threat may not come, as JD Vance suggested, "from within" – but from the US.
Fewer shortages and shared stockpiles are issues that need refining, some MEPs said
Official data found food prices rose 7.1% in February compared to last year
If the Finnish parliament approves the new regulation, it could come into force on 20 March.
Some rules exclude nuclear energy, which could however benefit from ot///hers.
For the first time the company sold more sausages than cars – the special ingredient? Innovation.
Among the funds on the chopping block is Horizon Europe – the €95 billion research programme and one of the bloc's best-known initiatives.
Tech Commissioner Henna Virkkunen will justify the withdrawal of the AI Liability Directive on 9 April in the JURI Committee of the European Parliament.
To be profitable on the US market amidst tariff tensions and business challenges, an expert suggests the company should "let go of the reins a little."
Bulgarian political instability has undermined its focus on the EU Pharma Package, risking innovation, investment and well-being.
The Committee is “working hard to push the Commission to propose legislation,” Committee Chair Li Andersson told Euractiv.
Pages